Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®
Published on 08/07/2025 at 18:05 | prnewswire.co.uk
Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal's footprint in the United States.With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol).Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly strengthening its profitability.View original content:https://www.prnewswire.co.uk/news-releases/grunenthal-acquires-us-company-valinor-pharma-and-becomes-global-owner-of-movantik-302202577.html
en | boerse | 67973172 |
